Jorge Boán

8PUBLICATIONS
23CO-AUTHORS
Disease surveillanceMedical bacteriologyCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 08, 2026
Role of ¹⁸F-FDG PET/CT in monitoring treatment response in extrapulmonary tuberculosis: a retrospective observational study.

|Aug 19, 2026
Epidemiology and Risk Factors for Infection in Multiple Myeloma Patients Treated With Bispecific Antibodies.

|Mar 11, 2026
Randomized double-blind clinical trial evaluating the effectiveness and safety of secondary prophylaxis with oral vancomycin versus placebo in the prevention of recurrence of clostridioides difficile infection in patients receiving systemic antibiotic therapy (PREVAN trial).

Rafael San-Juan, Julia Origüen, Mario Fernández-Ruiz

|Feb 20, 2026
Rezafungin for Salvage or Consolidation Therapy of Invasive Fungal Disease: Experience in Real-World Clinical Practice.

Jorge Boán, Eduardo Aparicio-Minguijón, Mario Fernández-Ruiz

|Dec 24, 2025
The Unnoticed Threat: Clinical Characteristics, Risk Factors, and Outcome of Mucormycosis in Solid Organ Transplantation.

Jorge Boán, Mario Fernández-Ruiz, Eduardo Aparicio-Minguijón

|Dec 01, 2025
Skin and Soft Tissue Mucormycosis in Patients Receiving Bruton Tyrosine Kinase Inhibitors: Case Report and Literature Review.

Eduardo Aparicio-Minguijón, Nieves López-Muñoz, Jorge Boán

Pageof 2

Frequent Collaborators

7 joint publications

Mario Fernández-Ruiz

7 joint publications

José María Aguado

6 joint publications

Eduardo Aparicio-Minguijón

5 joint publications

Francisco López-Medrano